The ECG: What is "normal"? by Scott Millar, Rob N
Many errors of clinical interpretation have arisen (and no
doubt may continue to arise) from a failure to recognise the
variability that is characteristic of man in all his measurable
features. Such variability between one person and another is
clearly a necessary and distinctive attribute of life. How then
in this situation can we define a “normal” value? On what
point of the scale should we begin to regard them as abnor-
mal, i.e. pathological?
Sir Austin Bradford Hill, 19771
The above quote identifies a problem common to medicine
and life in general. ‘Normality’ is partly a statistical 
concept, but also has philosophical and moral connota-
tions. The ECG occupies a special place in cardiac assess-
ment. A ‘normal’ ECG is very reassuring (often falsely),
whereas an abnormality may engender considerable 
anxiety both for the doctor and the patient. This is
particularly so when a well person has an ECG as part of a
‘check-up’.
The human electrocardiogram was first recorded 
by Augustus Waller in 1887,2 but the ECG as we know 
it was revealed to the world by William Eindhoven in
1901–1904.3 While recording methods differ, tracings
recorded by him are recognisable and analysable today.
What has changed over the century since then has 
been the huge increase in the usefulness of ECG recording,
as a result of continuous refinement. ECG analysis is
continually being informed by accumulated data of 
clinical syndromes, pathology, biochemical and genetic
information. For example, a new clinical/ECG syndrome
has been recognised as recently as 1992 (Brugada syn-
drome4) in which young survivors of ventricular fibrillation
cardiac arrest manifest characteristic ST segment and QRS
changes in V1 and V2. This syndrome has now been pinned
down to a single gene coding for part of the myocardial
sodium channel.
ECG analysis
The ECG can be analysed in terms of measurement and pat-
terns. Normal values for measurements of conduction, QRS
voltage and repolarisation are well established. Normal pat-
terns for P waves, QRS complexes, ST segment and T waves
are well-characterised. Deviations from these norms have
varying degrees of sensitivity and specificity for different
cardiac pathologies. Difficulties may arise with deviations
from normal values or patterns in people with no other evi-
dence of cardiac abnormality.
Why do we do ECGs?
The ECG is a widely available, cheap, non-invasive and
highly useful investigation, almost without parallel in mod-
ern medicine. It is frequently performed for a variety of indi-
cations:
• to confirm suspected pathologies, e.g. acute myocardial
infarction
• to decide on the mode of treatment, e.g. ST elevation ver-
sus ST depression in acute coronary syndromes
• to assess the rhythm
• to predict future morbidity and mortality
– clinically
– for insurance
• as part of a check-up to reassure the patient and ourselves
of ‘normality’.
The interpretation of ECG patterns and measurements
may differ, depending on the context and the reason the ECG
was performed. If an abnormality is detected in someone
with no symptoms or signs of cardiovascular disease, what
does it mean? Wrong interpretation may have serious conse-
quences, from missing serious and treatable pathology, to
engendering a cardiac neurosis in a healthy individual.
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Normal variation
The above problem is compounded if the practitioner is
ignorant of the huge variation in the normal ECG. Table I
lists some of the many factors which influence the electrical
activity of the heart as recorded from the body surface by
conventional ECG recording.
Assessment of an abnormal ECG in
an otherwise normal person
A number of abnormalities may be found in otherwise nor-
mal people, e.g. when an ECG is done for insurance purpos-
es. For example, a short PR interval and wide QRS due to a
delta wave (Wolff-Parkinson-White pattern) indicate the
presence of an accessory AV connection, even in the absence
of a history of tachycardias. While considered benign from
an insurance point of view, its significance to the individual
depends on the functional properties of the accessory path-
way and the person’s circumstances. Pathological Q waves
of silent myocardial infarction, patterns of left ventricular
hypertrophy with repolarisation changes due to hypertrophic
cardiomyopathy, bundle branch block, or a prolonged QT
interval all have prognostic implications, even in the absence
of symptoms.
Elite athletes pose special problems. The incidence of
ECG abnormalities is high5,6,7 and may suggest pathologies
known to be associated with an increased risk of sudden
death, e.g. hypertrophic cardiomyopathy (HCM) or arrhyth-
mogenic right ventricular cardiomyopathy (ARVC). Any
practitioner confronted with such a problem needs to be
aware of the range of patterns and changes in the ECG
known to be associated with the athlete’s heart. (See article
by Maznev et al. on page 12 of this issue.) 
Abnormalities of both measurements and patterns are
common. The main causes of the ECG changes are the high
vagal tone associated with a high level of physical fitness,
and increases in left ventricular volume and wall thickness,
particularly in endurance athletes. Table II lists some of the
abnormalities that have been described. Is it correct to call
these changes ‘abnormal’? In the sense that they are outside
of the range of statistical normality, the answer is yes. One
can hardly consider an elite Olympic athlete ‘normal’. He or
she is at the extreme of the distribution curve of ability and
physical capacity. ‘Supernormal’ might be an appropriate
description. In the sense of pathology, the answer is no. Very
few individuals with significant cardiac pathology attain the
heights of physical prowess required for competitive athlet-
ics of the kind associated commonly with ECG changes. An
athlete’s ‘abnormal’ ECG may be considered ‘normal’ in so
far as it does not predict present or future cardiac disease or
death. Studies have shown that the abnormalities tend to dis-
appear with prolonged cessation of training, confirming their
functional nature.
Despite the above, it is important to be aware that the
occasional athlete will have a potentially lethal cardiac
abnormality, manifesting initially only as an abnormal ECG.
Examples include HCM (said to be the leading cause of sud-
den death in young sportspersons in the USA8) and ARVC,
which in Italy accounts for the highest number of sudden
deaths during exercise.9 The ECG changes in both of these
conditions may be similar to those in normal highly trained
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– muscle noise, tremor (e.g. Parkinson’s)
– AC interference
– digitising artefacts e.g. pacemaker spikes
• labelling
TABLE II. ECG ABNORMALITIES IN ATHLETES
Rhythm
• sinus bradycardia
• sinus arrest with junctional escape
• sinus arrhythmia
• wandering atrial pacemaker
• first-degree AV block
• Wenckebach second-degree AV block
QRS complex
• increased left ventricular voltage
• increased right ventricular voltage
• rightward QRS axis
• incomplete right bundle branch block
Repolarisation changes
• ST segment elevation
• tall peaked T-waves
• biphasic T-waves 
• T-wave inversion
people. However, a combination of markedly increased left
ventricular voltage and repolarisation changes should
prompt careful echocardiographic examination for HCM as
well as asking about a family history of sudden death. The
echocardiographic differentiation of HCM from physiologic
hypertrophy may not be easy.10 A combination of T-wave
inversion in the right chest leads and ventricular arrhythmias
should raise the suspicion of ARVC and prompt further
investigation.
Conduction abnormalities, including Wenckebach sec-
ond-degree AV block and, rarely, transient complete heart
block, occur much more frequently in highly trained indi-
viduals than in the general population. High vagal tone is
thought to be responsible. The block will therefore only be
evident at rest, particularly while asleep, and will be associ-
ated with a slow sinus rate and sinus arrhythmia. In some
individuals, however, AV nodal conduction remains abnor-
mal after total autonomic blockade with atropine and pro-
pranolol. It may be that the increased vagal tone engendered
by the intense training may have unmasked the abnormality.
If the athlete can be persuaded to stop training (for up to sev-
eral months), the ECG changes related to training and high
vagal tone will return to normal. The same is true of the
structural changes in left and right ventricular dimensions.
The abnormal patterns of repolarisation, including ST-
segment elevation and T-wave inversion in the chest leads
are not confined to athletes. They may occur in otherwise
normal young people, particularly black Africans and
African-Americans.11 Several patterns were described by
Grusin in 1954 in black patients without heart disease at
Baragwanath Hospital.12
Conclusions
The range of normality of the ECG is very wide. The pat-
terns considered to be abnormal occasionally occur in indi-
viduals without other evidence of heart disease, particularly
in elite athletes and young black men. Awareness of the pos-
sibility will help to prevent undue anxiety and over-investi-
gation. Nevertheless, the ECG is occasionally the only clue
to a serious condition in an individual without symptoms.
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